- Home
- LCID vs HALO Comparison
LCID vs HALO Comparison
Compare LCID & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCID
- HALO
- Stock Information
- Founded
- LCID 2007
- HALO 1998
- Country
- LCID United States
- HALO United States
- Employees
- LCID N/A
- HALO N/A
- Industry
- LCID Auto Manufacturing
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LCID Consumer Discretionary
- HALO Health Care
- Exchange
- LCID Nasdaq
- HALO Nasdaq
- Market Cap
- LCID 6.7B
- HALO 7.6B
- IPO Year
- LCID N/A
- HALO N/A
- Fundamental
- Price
- LCID $21.67
- HALO $66.36
- Analyst Decision
- LCID Hold
- HALO Buy
- Analyst Count
- LCID 9
- HALO 11
- Target Price
- LCID $28.38
- HALO $73.09
- AVG Volume (30 Days)
- LCID 9.1M
- HALO 2.4M
- Earning Date
- LCID 11-05-2025
- HALO 10-30-2025
- Dividend Yield
- LCID N/A
- HALO N/A
- EPS Growth
- LCID N/A
- HALO 68.93
- EPS
- LCID N/A
- HALO 4.37
- Revenue
- LCID $928,991,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- LCID $66.00
- HALO $32.57
- Revenue Next Year
- LCID $92.69
- HALO $23.77
- P/E Ratio
- LCID N/A
- HALO $15.21
- Revenue Growth
- LCID 39.01
- HALO 34.97
- 52 Week Low
- LCID $15.25
- HALO $42.01
- 52 Week High
- LCID $36.40
- HALO $79.50
- Technical
- Relative Strength Index (RSI)
- LCID 61.64
- HALO 38.91
- Support Level
- LCID $20.66
- HALO $63.80
- Resistance Level
- LCID $25.22
- HALO $68.00
- Average True Range (ATR)
- LCID 1.23
- HALO 2.29
- MACD
- LCID -0.94
- HALO -0.89
- Stochastic Oscillator
- LCID 22.15
- HALO 20.48
About LCID Lucid Group Inc.
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations and through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.